Junhang Chen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Junhang Chen has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Longhao Sun
Department of General Surgery, Tianjin Medical University General Hospital, Tianjin 300052, China
3 shared publications - Tiantian Yang
Department of General Surgery, Tianjin Medical University General Hospital, Tianjin 300052, China
2 shared publications - Yang Zhang
Department of General Surgery, Tianjin Medical University General Hospital, Tianjin 300052, China
2 shared publications - Xiangchen Dai
Department of Vascular Surgery, Tianjin Medical University General Hospital, Tianjin, China
1 shared publication - Xiaoyu Liang
Department of General Surgery, Tianjin Medical University General Hospital, Tianjin 300052, China
1 shared publication - Xiaoyu Liang
Department of General Surgery, Tianjin Medical University General Hospital, Tianjin 300052, China
1 shared publication
Latest Publications
- Open Access
- 2 November 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (21) , 8514
Altered Hepatic Hydrogen Sulfide-Related Homeostasis in Metabolic Dysfunction-Associated Steatotic Liver Disease and Its Changes Following Sleeve Gastrectomy
Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) is closely associated with obesity and metabolic dysfunction. Hydrogen sulfide (H2S) is involved in hepatic glucose and lipid metabolism and redox homeostasis, but alterations in hepatic H2S-related homeostasis in MASLD and their changes following sleeve gastrectomy (SG) remain incompletely understood. This study investigated hepatic H2S metabolism in MASLD and its changes following SG. Methods: Liver tissues from five patients with MASLD and five non-MASLD controls were analyzed for histology, H2S levels, and expression of cystathionine β-synthase (CBS), cystathionine γ-lyase (CSE), and 3-mercaptopyruvate sulfurtransferase (MPST) by qPCR, Western blotting, and immunohistochemistry. A high-fat diet-induced obese rat model was used to evaluate the metabolic, biochemical, histological, and hepatic H2S-related effects of SG. Results: Patients with MASLD showed marked hepatic steatosis, a reduced hepatic H2S-related sulfide pool and CSE expression, increased MPST expression, and unchanged CBS expression. Similar alterations were observed in obese rats. Compared with Sham rats, SG reduced body weight and food intake, improved glucose and lipid metabolism and liver function, and attenuated hepatic steatosis. These improvements were accompanied by an increased hepatic H2S-related sulfide pool and CSE expression and decreased MPST expression, whereas CBS remained stable. Conclusions: MASLD was associated with altered hepatic H2S-related homeostasis characterized by a reduced H2S-related sulfide pool, decreased CSE expression, increased MPST expression, and relatively stable CBS expression. In obese rats, metabolic improvement following SG was accompanied by corresponding changes in hepatic H2S-related homeostasis toward the pattern observed in controls. Whether these H2S-related changes contribute functionally to the metabolic benefits of SG remains to be determined.
- 2 November 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (21) , 8514
Open AccessAltered Hepatic Hydrogen Sulfide-Related Homeostasis in Metabolic Dysfunction-Associated Steatotic Liver Disease and Its Changes Following Sleeve Gastrectomy
Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) is closely associated with obesity and metabolic dysfunction. Hydrogen sulfide (H2S) is involved in hepatic glucose and lipid metabolism and redox homeostasis, but alterations in hepatic H2S-related homeostasis in MASLD and their changes following sleeve gastrectomy (SG) remain incompletely understood. This study investigated hepatic H2S metabolism in MASLD and its changes following SG. Methods: Liver tissues from five patients with MASLD and five non-MASLD controls were analyzed for histology, H2S levels, and expression of cystathionine β-synthase (CBS), cystathionine γ-lyase (CSE), and 3-mercaptopyruvate sulfurtransferase (MPST) by qPCR, Western blotting, and immunohistochemistry. A high-fat diet-induced obese rat model was used to evaluate the metabolic, biochemical, histological, and hepatic H2S-related effects of SG. Results: Patients with MASLD showed marked hepatic steatosis, a reduced hepatic H2S-related sulfide pool and CSE expression, increased MPST expression, and unchanged CBS expression. Similar alterations were observed in obese rats. Compared with Sham rats, SG reduced body weight and food intake, improved glucose and lipid metabolism and liver function, and attenuated hepatic steatosis. These improvements were accompanied by an increased hepatic H2S-related sulfide pool and CSE expression and decreased MPST expression, whereas CBS remained stable. Conclusions: MASLD was associated with altered hepatic H2S-related homeostasis characterized by a reduced H2S-related sulfide pool, decreased CSE expression, increased MPST expression, and relatively stable CBS expression. In obese rats, metabolic improvement following SG was accompanied by corresponding changes in hepatic H2S-related homeostasis toward the pattern observed in controls. Whether these H2S-related changes contribute functionally to the metabolic benefits of SG remains to be determined.
- Open Access
- 24 October 2023
- Published by MDPI AG in Biomedicines
- Vol. 11 (11) , 2874
MiR-506 Promotes Antitumor Immune Response in Pancreatic Cancer by Reprogramming Tumor-Associated Macrophages toward an M1 Phenotype
Pancreatic ductal adenocarcinoma (PDAC) is a highly malignant cancer with a poor prognosis, and effective treatments for PDAC are lacking. In this study, we hypothesized that miR-506 promotes antitumor immune response in PDAC by reprogramming tumor-associated macrophages toward an M1 phenotype to reverse its immunosuppressive tumor microenvironment (TME). First, the relationship between TME and the expression of miR-506 was assessed using clinical samples. Our results provided evidence that lower expression of miR-506 was associated with poor prognosis and immunosuppressive TME in PDAC patients. In addition, miR-506 inhibit the PDAC progression and reversed its immunosuppressive microenvironment in a macrophage-dependent manner. Next, we established a PDAC mouse model by orthotopic injection to further explore the role of miR-506 in vivo. Mechanistic investigations demonstrated that miR-506 could reprogram the polarization of M2-like macrophages toward an M1-like phenotype through targeting STAT3. Meanwhile, miR-506 could also sensitize PDAC to anti-PD-1 immunotherapy, because the tumor microenvironment remodeling effects of miR-506 could reprogram macrophage polarization and subsequently promote cytotoxic T lymphocyte (CTL) infiltration. These findings suggest a relationship between miR-506 and TME, especially M2-like macrophages, thus providing novel insights into mechanisms of tumor progression and potential immunotherapeutic targets for further clinical treatment.
- 24 October 2023
- Published by MDPI AG in Biomedicines
- Vol. 11 (11) , 2874
Open AccessMiR-506 Promotes Antitumor Immune Response in Pancreatic Cancer by Reprogramming Tumor-Associated Macrophages toward an M1 Phenotype
Pancreatic ductal adenocarcinoma (PDAC) is a highly malignant cancer with a poor prognosis, and effective treatments for PDAC are lacking. In this study, we hypothesized that miR-506 promotes antitumor immune response in PDAC by reprogramming tumor-associated macrophages toward an M1 phenotype to reverse its immunosuppressive tumor microenvironment (TME). First, the relationship between TME and the expression of miR-506 was assessed using clinical samples. Our results provided evidence that lower expression of miR-506 was associated with poor prognosis and immunosuppressive TME in PDAC patients. In addition, miR-506 inhibit the PDAC progression and reversed its immunosuppressive microenvironment in a macrophage-dependent manner. Next, we established a PDAC mouse model by orthotopic injection to further explore the role of miR-506 in vivo. Mechanistic investigations demonstrated that miR-506 could reprogram the polarization of M2-like macrophages toward an M1-like phenotype through targeting STAT3. Meanwhile, miR-506 could also sensitize PDAC to anti-PD-1 immunotherapy, because the tumor microenvironment remodeling effects of miR-506 could reprogram macrophage polarization and subsequently promote cytotoxic T lymphocyte (CTL) infiltration. These findings suggest a relationship between miR-506 and TME, especially M2-like macrophages, thus providing novel insights into mechanisms of tumor progression and potential immunotherapeutic targets for further clinical treatment.
- Open Access
- 3 December 2022
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 12 (12) , 2005
IGFBP2 Drives Regulatory T Cell Differentiation through STAT3/IDO Signaling Pathway in Pancreatic Cancer
Pancreatic ductal adenocarcinoma (PDAC) represents one of the deadliest malignancies. Elevated regulatory T cell (Treg) infiltration has a potent immunosuppressive function in tumor biology, which contributes to low survival in PDAC. Nonetheless, the crosstalk between malignant cells and tumor-infiltrating Tregs in PDAC is not well understood. Here, clinical data demonstrates that the insulin-like growth factor binding protein 2 (IGFBP2) is associated with Treg accumulation in the microenvironment of PDAC in humans. Additionally, IGFBP2 increases Treg infiltration in the tumor microenvironment and promotes disease progression in mouse PDAC. Bioinformatic analysis and mechanistic assessment reveals IGFBP2 upregulated indoleamine 2, 3-dioxygenase (IDO) by activating signal transducer and activator of transcription 3 (STAT3) signaling in PDAC cells, thus inducing Treg differentiation and an immunosuppressive tumor microenvironment. These findings provide mechanistic insights into an important molecular pathway that promotes an immunosuppressive microenvironment, which suggests the IGFBP2 axis as a potential target for improved immune response in PDAC.
- 3 December 2022
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 12 (12) , 2005
Open AccessIGFBP2 Drives Regulatory T Cell Differentiation through STAT3/IDO Signaling Pathway in Pancreatic Cancer
Pancreatic ductal adenocarcinoma (PDAC) represents one of the deadliest malignancies. Elevated regulatory T cell (Treg) infiltration has a potent immunosuppressive function in tumor biology, which contributes to low survival in PDAC. Nonetheless, the crosstalk between malignant cells and tumor-infiltrating Tregs in PDAC is not well understood. Here, clinical data demonstrates that the insulin-like growth factor binding protein 2 (IGFBP2) is associated with Treg accumulation in the microenvironment of PDAC in humans. Additionally, IGFBP2 increases Treg infiltration in the tumor microenvironment and promotes disease progression in mouse PDAC. Bioinformatic analysis and mechanistic assessment reveals IGFBP2 upregulated indoleamine 2, 3-dioxygenase (IDO) by activating signal transducer and activator of transcription 3 (STAT3) signaling in PDAC cells, thus inducing Treg differentiation and an immunosuppressive tumor microenvironment. These findings provide mechanistic insights into an important molecular pathway that promotes an immunosuppressive microenvironment, which suggests the IGFBP2 axis as a potential target for improved immune response in PDAC.